Eosinophil extracellular trap formation is closely associated with disease severity in chronic rhinosinusitis regardless of nasal polyp status.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
30 05 2019
Historique:
received: 16 01 2019
accepted: 16 05 2019
entrez: 1 6 2019
pubmed: 31 5 2019
medline: 24 10 2020
Statut: epublish

Résumé

Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory airway disease involving non-eosinophilic and eosinophilic phenotypes, which translate to various endotypes. Activated eosinophils and neutrophils are known to generate extracellular traps consisting of DNA and cytotoxic granule proteins. We sought to investigate the presence of eosinophil and neutrophil extracellular traps (EETs and NETs, respectively) in human CRS tissues and to clarify the associations with their clinical features. Nasal polyp (NP) or ethmoid tissue slides of 43 subjects from endoscopic sinus surgery for CRS were analysed. Quantitative analysis of EETs and NETs was performed by confocal microscopy using immunofluorescent staining. For correlation study, the presence of NPs, number of infiltrating tissue eosinophils, preoperative Lund-Mackay scores, and other comorbidities were analysed. EET formation was observed to varying degrees in all CRS groups and was correlated with the number of tissue eosinophils (r  =  0.83, p  < 0.001) regardless of the presence of NPs. Patients with more EETs demonstrated higher Lund-Mackay scores (r  =  0.51, p  = 0.009), blood eosinophilia (r  =  0.80, p  < 0.001), and decreased olfactory function (r  = -0.65, p  < 0.001). No correlation between the extent of EET formation and the presence of atopy or asthma was apparent. However, none of the CRS groups containing neutrophils formed NETs in this study. Eosinophilic CRS indicates the presence of EETs. Formation of EETs could have a role in clinical decision-making and prediction of treatment outcome of CRS, regardless of NP status.

Identifiants

pubmed: 31147604
doi: 10.1038/s41598-019-44627-z
pii: 10.1038/s41598-019-44627-z
pmc: PMC6542829
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8061

Références

Rhinology. 1993 Dec;31(4):183-4
pubmed: 8140385
Allergy. 2015 Aug;70(8):995-1003
pubmed: 25945591
J Allergy Clin Immunol. 2016 Nov;138(5):1344-1353
pubmed: 27544740
Blood. 2018 Nov 15;132(20):2183-2187
pubmed: 30154112
Curr Opin Immunol. 2012 Dec;24(6):736-9
pubmed: 22981682
Otolaryngol Head Neck Surg. 2010 Jan;142(1):64-71
pubmed: 20096225
JAMA Otolaryngol Head Neck Surg. 2016 Aug 1;142(8):731-7
pubmed: 27228459
Yonsei Med J. 2018 Mar;59(2):325-330
pubmed: 29436203
J Allergy Clin Immunol. 2017 Feb;139(2):699-703.e7
pubmed: 27639939
J Allergy Clin Immunol. 2016 Jan;137(1):258-267
pubmed: 26070883
J Allergy Clin Immunol. 2017 Jan;139(1):212-219.e3
pubmed: 27458052
Curr Allergy Asthma Rep. 2016 Jul;16(8):54
pubmed: 27393701
Rhinol Suppl. 2012 Mar;23:3 p preceding table of contents, 1-298
pubmed: 22764607
Nat Med. 2008 Sep;14(9):949-53
pubmed: 18690244
Allergy. 2013 Apr;68(4):409-16
pubmed: 23409745
J Allergy Clin Immunol. 2013 Jun;131(6):1479-90
pubmed: 23587334
J Allergy Clin Immunol. 2017 Nov;140(5):1230-1239
pubmed: 28987810
J Allergy Clin Immunol. 2016 May;137(5):1449-1456.e4
pubmed: 26949058
Allergy. 2016 Mar;71(3):295-307
pubmed: 26606240
Auris Nasus Larynx. 2009 Jun;36(3):280-6
pubmed: 18775610
Allergy Asthma Immunol Res. 2017 Jul;9(4):299-306
pubmed: 28497916
Science. 2004 Mar 5;303(5663):1532-5
pubmed: 15001782
J Allergy Clin Immunol. 2017 Jun;139(6):1849-1860.e6
pubmed: 28216437
Curr Allergy Asthma Rep. 2017 May;17(5):33
pubmed: 28455742
J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):621-8
pubmed: 27393777
Allergy. 2006 Nov;61(11):1280-9
pubmed: 17002703
J Allergy Clin Immunol. 2011 May;127(5):1260-6
pubmed: 21315435
Allergy. 2015 Apr;70(4):443-52
pubmed: 25620273
Allergy. 2012 Sep;67(9):1127-37
pubmed: 22764833
Int Forum Allergy Rhinol. 2017 Oct;7(10):957-962
pubmed: 28742240

Auteurs

Chi Sang Hwang (CS)

Department of Otorhinolaryngology, Yonsei University Wonju College of Medicine, Wonju, South Korea.
Department of Medicine, Graduate School, Yonsei University College of Medicine, Seoul, South Korea.

Sang Chul Park (SC)

Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, South Korea.

Hyung-Ju Cho (HJ)

Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, South Korea.
The Airway Mucus Institute, Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea.

Dong-Joon Park (DJ)

Department of Otorhinolaryngology, Yonsei University Wonju College of Medicine, Wonju, South Korea.

Joo-Heon Yoon (JH)

Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, South Korea.
The Airway Mucus Institute, Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea.

Chang-Hoon Kim (CH)

Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, South Korea. entman@yuhs.ac.
The Airway Mucus Institute, Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea. entman@yuhs.ac.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH